Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
- Published In:
- Blood advances, 3(20), 2920-2933 (2019)
- Authors:
- Pramil, Elodie, Herbi Bastian, Linda, Denèfle, Thomas, Nemati, Fariba, Xiao, Malina, Lardé, Eva, Maloum, Karim, Roos-Weil, Damien, Chapiro, Elise, Le Garff-Tavernier, Magali, Davi, Frédéric, Decaudin, Didier, Sarfati, Marika, Nguyen-Khac, Florence, Merle-Béral, Hélène, Karoyan, Philippe, Susin, Santos A
- Database ID:
- RPEP-04427
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04427APA
Pramil, Elodie; Herbi Bastian, Linda; Denèfle, Thomas; Nemati, Fariba; Xiao, Malina; Lardé, Eva; Maloum, Karim; Roos-Weil, Damien; Chapiro, Elise; Le Garff-Tavernier, Magali; Davi, Frédéric; Decaudin, Didier; Sarfati, Marika; Nguyen-Khac, Florence; Merle-Béral, Hélène; Karoyan, Philippe; Susin, Santos A. (2019). Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.. Blood advances, 3(20), 2920-2933. https://doi.org/10.1182/bloodadvances.2019000350
MLA
Pramil, Elodie, et al. "Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.." Blood advances, 2019. https://doi.org/10.1182/bloodadvances.2019000350
RethinkPeptides
RethinkPeptides Research Database. "Targeting chronic lymphocytic leukemia with N-methylated thr..." RPEP-04427. Retrieved from https://rethinkpeptides.com/research/pramil-2019-targeting-chronic-lymphocytic-leukemia
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.